Nonpartisan civic infrastructure
AllCiv·Legis1
·

S. 765

BillFederalSenateIn Committee
To amend title XVIII of the Social Security Act to provide hereditary cancer genetic testing for individuals with a history of a hereditary cancer gene mutation in a blood relative or a personal or ancestral history suspicious for hereditary cancer, and to provide coverage of certain cancer screenings or preventive surgeries that would reduce the risk for individuals with a germline (inherited) mutation associated with a high risk of developing a preventable cancer.
About This Bill
Committee
Latest Action · March 9, 2023
Read twice and referred to the Committee on Finance.
Congress
118th (2023–2025)
Introduced
March 9, 2023
Cosponsors (2)
2D 0R
View PDF ↗

Summary

Highlight any text to annotate
Reducing Hereditary Cancer Act of 2023 This bill provides for Medicare coverage of germline mutation testing for individuals with a personal or family history of a hereditary cancer gene mutation or suspected history of hereditary cancer, as well as for associated coverage of risk-reducing surgeries and screenings.

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.